Drug response screening of leukemia stem cells offers clues to relapse and suggests ways to improve patient-specific therapies Advances in rapid screening of leukemia cells for drug susceptibility and resistance […] Read More
Researchers built an algorithm to discern which drugs might best combat patients’ individual cases of acute myeloid leukemia. The statistics are grim. For patients fighting an aggressive form of leukemia known as acute myeloid leukemia, or AML, doctors over the last 40 years have usually used a combination of two drugs to fight the disease, but it seldom cures it. Read More
Congratulations to ISCRM’s Pam Becker, who was selected as the 2015 Faculty Award winner by the graduating Hematology/Oncology fellows at the annual fellow’s graduation ceremony that took place Monday, June […] Read More